-
Dianthus Therapeutics, Inc. (NASDAQ:DNTH) Given Consensus Rating of "Buy" by Analysts
ソース: Buzz FX / 07 11 2024 00:51:16 America/Chicago
Dianthus Therapeutics, Inc. (NASDAQ:DNTH) Given Consensus Rating of "Buy" by Analysts Written by MarketBeat November 7, 2024 Share Link copied to clipboard. Shares of Dianthus Therapeutics, Inc. ( NASDAQ:DNTH - Get Free Report ) have earned
Read more...